- Efficacy and safety of antiplatelet-combination therapy after drug-eluting stent implantation
-
Cho YK, Nam CW, Park HS, Yoon HJ, Kim H, Hur SH, Kim YN, Lee JH, Yang DH, Lee BR, Jung BC, Kim W, Park JS, Lee JB, Kim KS, Kim KB
- KMID: 1792037
- Korean J Intern Med.
- 2014 Mar;29(2):210-216.
- doi: 10.3904/kjim.2014.29.2.210
BACKGROUND/AIMS: Combination single-pill therapy can improve cost-effectiveness in a typical medical therapy. However, there is a little evidence about the efficacy and tolerability of combination single-pill antiplatelet therapy after percutaneous... -
- CITED
-
- Close
- SHARE
-
- Close
- The Impact of Generic Clopidogrel Bisulfate on Platelet Inhibition in Patients with Coronary Artery Stents: Results of the ACCEL-GENERIC Study
-
Jeong YH, Koh JS, Kang MK, Ahn YJ, Kim IS, Park Y, Hwang SJ, Kwak CH, Hwang JY
- KMID: 1785672
- Korean J Intern Med.
- 2010 Jun;25(2):154-161.
- doi: 10.3904/kjim.2010.25.2.154
BACKGROUND/AIMS: In patients with coronary artery stents, the cost of clopidogrel has been cited as a factor in the premature discontinuation of therapy. Thus, the introduction of lower-cost generic clopidogrel... -
- CITED
-
- Close
- SHARE
-
- Close
- Detection of Clopidogrel Hyporesponsiveness Using a Point-of-Care Assay and the Impact of Additional Cilostazol Administration after Coronary Stent Implantation in Diabetic Patients
-
Yang TH, Kim DI, Kim DK, Jang JS, Kim U, Seol SH, Kim DK, Hong GR, Park JS, Shin DG, Kim YJ, Cho YK, Nam CW, Hur SH, Kim KB, Kim DS
- KMID: 1776586
- Korean J Intern Med.
- 2011 Jun;26(2):145-152.
- doi: 10.3904/kjim.2011.26.2.145
BACKGROUND/AIMS: Impaired responsiveness to clopidogrel is common in patients with type 2 diabetes mellitus (DM). The aim of this study was to evaluate the clinical application of a point-of-care assay... -
- CITED
-
- Close
- SHARE
-
- Close
